CDK7 and cancer: Importantly, RA, inhibitors of HDACs, BET bromodomain containing proteins, CDK7, CDK9 and small molecules that bind to G4s have been demonstrated to be effective for the treatment of many types of cancers by targeting their dysregulated transcriptional programs (109, 110).